Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles

Harbour Bio to Start China Trials of CLTA-4/PD-1 Combo in Two Additional Cancers
Everest in $500 Million Deal for mRNA Products, including COVID-19 Vaccine
Legend Bio Starts US Trial of CD4 CAR-T Therapy for Lymphoma
Week in Review: Sanofi Acquires Kadmon, a US-China Pharma, for $1.9 Billion
Huadong and Insilico Partner to Discover Novel Oncology Candidates
Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021